The Effects of Low Energy Availability and High Impact Jumping on Markers of Bone (re)Modelling in Females
The Effects of Short-term Low Energy Availability and Low Repetition High Impact Jumping on Markers of Bone Formation and Resorption in Young Females
1 other identifier
interventional
19
1 country
1
Brief Summary
Osteoporosis is worldwide health epidemic categorized by poor bone health, primarily diagnosed by low bone mineral density, and costs healthcare systems billions every year. Athletes and exercising people who expend large amounts of energy in physical activity, or restrict diet in order to lose weight, are at risk of low energy availability. This is when an individual fails to match their exercise energy demand with a appropriate dietary intake in order to maintain optimal physiological function; which can lead to low bone mineral density, osteoporosis both early and later in life and an increased risk of injury. Runners are particularly susceptible to stress fracture in response to low energy availability due to repetitive ground impact. Research shows that as little as five days low energy availability significantly reduces bone formation, and significantly increases bone resorption, in physically active women. The ideal solution is to restore energy availability; however, this is often very difficult during periods of intense training and conflicts with the goal of weight loss. Therefore, there is a need to develop an alternative tool to protect bone health. It is critical that any exercise intervention does not further reduce energy availability as previous research shows that this accelerates bone loss rather than prevents it. Low repetition high impact jumping exercise is highly beneficial to bone health and has been shown to improve bone structure when used as a long-term intervention in energy replete states. It takes very little time to complete and uses a very small amount of energy. However, no study to date has examined the effects of such an intervention during low energy availability. The current study will investigate whether low repetition high impact jumping prevents or reduces the reduction in bone formation and the increase in bone resorption experienced during five days of low energy availability and findings will have implications on athletic and recreational training recommendations in order to protect bone health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2020
CompletedStudy Start
First participant enrolled
November 1, 2020
CompletedFirst Posted
Study publicly available on registry
March 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedFebruary 14, 2023
February 1, 2023
1.7 years
October 2, 2020
February 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in blood pro-peptide of type 1 collagen (P1NP) concentration
P1NP is a marker of bone resorption and it will be measured during the fasted state
of dietary provision to the same time on the morning following the final day of dietary provision (three days later), in each condition
Change in blood β-carboxyl-terminal cross-linked telopeptide of type 1 collagen (β-CTx) concentration
β-CTx is a marker of bone formation and it will be measured during the fasted state
of dietary provision to the same time on the morning following the final day of dietary provision (three days later), in each condition
Secondary Outcomes (17)
Change in blood 17β-oestradiol concentration
of dietary provision to the same time on the morning following the final day of dietary provision (three days later), in each condition
Change in blood triiodothyronine (T3) concentration
of dietary provision to the same time on the morning following the final day of dietary provision (three days later), in each condition
Change in blood β-hydroxybutyrate (β-OHB) concentration
of dietary provision to the same time on the morning following the final day of dietary provision (three days later), in each condition
Change in blood calcium concentration
of dietary provision to the same time on the morning following the final day of dietary provision (three days later), in each condition
Change in blood magnesium concentration
of dietary provision to the same time on the morning following the final day of dietary provision (three days later), in each condition
- +12 more secondary outcomes
Study Arms (2)
Low energy availability
EXPERIMENTALIntervention involves three of dietary energy restriction providing 15 kilo-calories per kilogram of fat-free mass per day.
Low energy availability and high impact jumping
EXPERIMENTALIntervention involves three days of dietary energy restriction providing 15 kilo-calories per kilogram of fat-free mass per day and brief high impact jumping exercise performed daily in the morning and in the evening.
Interventions
Participants will be provided with food to eat every day and will not be permitted to consume any other calorie containing foods or beverages. This amount of energy contained within the food provided will be one third of that contained in the food provided in the control condition (45 kilo-calories per kilogram of fat-free mass per day) and will be standardized between and within participants for carbohydrate, protein and fat composition.
Participants will perform a brief session of high impact jumping every morning (10 maximum effort vertical counter-movement jumps, and 5 maximum effort lateral drop jumps in each direction) and a similar session of high impact jumping every evening (20 maximum effort vertical counter-movement jumps).
Eligibility Criteria
You may qualify if:
- Menstrual cycles that are between 21 - 35 days in length for at least the previous three cycles
- Regular length of menstrual cycle (less than six days difference between cycles) for at least the previous three cycles
- Body mass index between 18.5 - 30 kg.m squared
- Weight stable for the past three months and not currently dieting
You may not qualify if:
- Smoker
- Pregnant
- Vegan
- Have used hormonal contraception at any point within the previous three months
- Regularly engage in \>3 vigorous, or \>5 moderate, exercise sessions a week
- Compete regularly in a high or multi-directional impact sport at national level or higher
- Have sustained a bone injury within the previous twelve months
- Have sustained any injury within the past six months that restricted their ability to exercise
- Taken hormone replacement therapy (HRT) at any point during the past three months
- Have been previously diagnosed with an eating disorder
- Have taken any medications (other than vitamin or mineral supplements) known to effect bone metabolism within the previous three months (e.g. glucocorticoids, anticonvulsants or anabolic steroids)
- Have previously been diagnosed with a medical condition known to impact bone health (e.g. hypothyroidism, hyperthyroidism, diabetes mellitus, hypercortisolism and renal or gastrointestinal disease)
- Have previously been diagnosed with a pathology known to impact menstrual function (e.g. primary ovarian insufficiency, hyperprolactinemia, thyroid dysfunction, polycystic ovarian syndrome and any other conditions of androgen excess)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mark Hutson
Loughborough, Leicestershire, LE11 3TU, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard C Blagrove, PhD
Loughborough University
- STUDY DIRECTOR
Emma O'Donnell, PhD
Loughborough University
- STUDY DIRECTOR
Katherine SF Brooke-Wavell, PhD
Loughborough University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
October 2, 2020
First Posted
March 10, 2021
Study Start
November 1, 2020
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
February 14, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share